Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Conditions:   Uterine Neoplasms;   Uterine Cervical Neoplasms;   Biliary Tract Neoplasms;   Urologic Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Breast Neoplasms Interventions:   Drug: tucatinib;   Drug: trastuzumab;   Drug: fulvestrant Sponsor:   Seattle Genetics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials